Correlation Between Roivant Sciences and BriaCell Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Roivant Sciences and BriaCell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Roivant Sciences and BriaCell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Roivant Sciences and BriaCell Therapeutics Corp, you can compare the effects of market volatilities on Roivant Sciences and BriaCell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Roivant Sciences with a short position of BriaCell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Roivant Sciences and BriaCell Therapeutics.

Diversification Opportunities for Roivant Sciences and BriaCell Therapeutics

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Roivant and BriaCell is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Roivant Sciences and BriaCell Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BriaCell Therapeutics and Roivant Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Roivant Sciences are associated (or correlated) with BriaCell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BriaCell Therapeutics has no effect on the direction of Roivant Sciences i.e., Roivant Sciences and BriaCell Therapeutics go up and down completely randomly.

Pair Corralation between Roivant Sciences and BriaCell Therapeutics

Given the investment horizon of 90 days Roivant Sciences is expected to generate 0.39 times more return on investment than BriaCell Therapeutics. However, Roivant Sciences is 2.59 times less risky than BriaCell Therapeutics. It trades about 0.05 of its potential returns per unit of risk. BriaCell Therapeutics Corp is currently generating about 0.0 per unit of risk. If you would invest  700.00  in Roivant Sciences on August 30, 2024 and sell it today you would earn a total of  569.00  from holding Roivant Sciences or generate 81.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.19%
ValuesDaily Returns

Roivant Sciences  vs.  BriaCell Therapeutics Corp

 Performance 
       Timeline  
Roivant Sciences 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Roivant Sciences are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable forward indicators, Roivant Sciences is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
BriaCell Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in BriaCell Therapeutics Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, BriaCell Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Roivant Sciences and BriaCell Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Roivant Sciences and BriaCell Therapeutics

The main advantage of trading using opposite Roivant Sciences and BriaCell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Roivant Sciences position performs unexpectedly, BriaCell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BriaCell Therapeutics will offset losses from the drop in BriaCell Therapeutics' long position.
The idea behind Roivant Sciences and BriaCell Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
CEOs Directory
Screen CEOs from public companies around the world